Open Access
J Oral Med Oral Surg
Volume 28, Number 4, 2022
Article Number 40
Number of page(s) 11
Published online 22 November 2022
  1. Carvalho PAG, Jaguar GC, Pellizzon AC, Prado JD, Lopes RN, Alves FA. Evaluation of low-level laser therapy in the prevention and treatment of radiation-induced mucositis: a double-blind randomized study in head and neck cancer patients. Oral Oncol 2011;47:1176–1181. [CrossRef] [PubMed] [Google Scholar]
  2. Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Guddattu V. Low level laser therapy against radiation induced oral mucositis in elderly head and neck cancer patients – a randomized placebo controlled trial. J Photochem Photobiol B mars 2015;144:51–56. [CrossRef] [Google Scholar]
  3. Brandão TB, Morais-Faria K, Ribeiro ACP, Rivera C, Salvajoli JV, Lopes MA, et al. Locally advanced oral squamous cell carcinoma patients treated with photobiomodulation for prevention of oral mucositis: retrospective outcomes and safety analyses. Support Care Cancer 2018;26:2417–2423. [CrossRef] [PubMed] [Google Scholar]
  4. Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya AG, Nigudgi S. Effect of low-level laser therapy on patient reported measures of oral mucositis and quality of life in head and neck cancer patients receiving chemoradiotherapy—a randomized controlled trial. Support Care Cancer 2013;21:1421–1428. [CrossRef] [PubMed] [Google Scholar]
  5. Genot-Klastersky MT, Paesmans M, Ameye L, Kayumba A, Beauvois S, Dragan T, et al. Retrospective evaluation of the safety of low-level laser therapy/photobiomodulation in patients with head/neck cancer. Support Care Cancer 2020;28:3015–3022. [CrossRef] [PubMed] [Google Scholar]
  6. Legouté F, Bensadoun RJ, Seegers V, Pointreau Y, Caron D, Lang P, et al. Low-level laser therapy in treatment of chemoradiotherapy-induced mucositis in head and neck cancer: results of a randomised, triple blind, multicentre phase III trial. Radiat Oncol 2019;14:83. [CrossRef] [PubMed] [Google Scholar]
  7. Zecha JA, Raber-Durlacher JE, Nair RG, Epstein JB, Bensadoun RJ. et al. Low level laser therapy/photobiomodulation in the management of side effects of chemoradiation therapy in head and neck cancer: part 1: mechanisms of action, dosimetric, and safety considerations. Support Care Cancer 2016;24:2781–2792. [CrossRef] [PubMed] [Google Scholar]
  8. Elad S. The MASCC/ISOO mucositis guidelines 2019: the second set of articles and future directions. Support Care Cancer 2020;s00520-019-05153-w. [Google Scholar]
  9. Antunes HS, Herchenhorn D, Small IA, Araújo CMM, Viégas CMP, de Assis Ramos G, et al. Long-term survival of a randomized phase III trial of head and neck cancer patients receiving concurrent chemoradiation therapy with or without low-level laser therapy (LLLT) to prevent oral mucositis. Oral Oncol 2017;71:11–15. [CrossRef] [PubMed] [Google Scholar]
  10. Oton-Leite AF, Elias LSA, Morais MO, Pinezi JCD, Leles CR, Silva MAGS, et al. Effect of low level laser therapy in the reduction of oral complications in patients with cancer of the head and neck submitted to radiotherapy: LLLT for oral complications in cancer patients. Spec Care Dentist 2013;33:294–300. [CrossRef] [PubMed] [Google Scholar]
  11. Gouvêa de Lima A, Villar RC, de Castro G, Antequera R, Gil E, Rosalmeida MC, et al. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study. Int J Radiat Oncol 2012;82:270–275. [CrossRef] [Google Scholar]
  12. de Dantas JBL, Martins GB, Lima HR, Carrera M, de Reis SRA, Medrado ARAP. Evaluation of preventive laser photobiomodulation in patients with head and neck cancer undergoing radiochemotherapy: laser in patients with head and neck cancer. Spec Care Dentist 2020;40:364–373. [CrossRef] [PubMed] [Google Scholar]
  13. Martins AFL, Nogueira TE, Morais MO, Oton-Leite AF, Valadares MC, Batista AC, et al. Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial. Trials 2019;20:97. [CrossRef] [PubMed] [Google Scholar]
  14. Oton-Leite AF, Silva GBL, Morais MO, Silva TA, Leles CR, Valadares MC, et al. Effect of low-level laser therapy on chemoradiotherapy-induced oral mucositis and salivary inflammatory mediators in head and neck cancer patients: EFFECT OF LOW-LEVEL LASER THERAPY IN CANCER PATIENTS. Lasers Surg Med avr 2015;47:296–305. [CrossRef] [PubMed] [Google Scholar]
  15. Zanin T, Zanin F, Carvalhosa AA, de Souza Castro PH, Pacheco MT, Zanin ICJ, et al. Use of 660-nm Diode Laser in the Prevention and Treatment of Human Oral Mucositis Induced by Radiotherapy and Chemotherapy. Photomed Laser Surg avr 2010;28:233–237. [CrossRef] [PubMed] [Google Scholar]
  16. Marín-Conde F, Castellanos-Cosano L, Pachón-Ibañez J, Serrera-Figallo MA, Gutiérrez-Pérez JL, Torres-Lagares D. Photobiomodulation with low-level laser therapy reduces oral mucositis caused by head and neck radio-chemotherapy: prospective randomized controlled trial. Int J Oral Maxillofac Surg juill 2019;48:917–923. [CrossRef] [Google Scholar]
  17. Soares RG, Farias LC, da Silva Menezes AS, de Oliveira e Silva CS, Tabosa ATL, Chagas PVF, et al. Treatment of mucositis with combined 660- and 808-nm-wavelength low-level laser therapy reduced mucositis grade, pain, and use of analgesics: a parallel, single-blind, two-arm controlled study. Lasers Med Sci nov 2018;33:1813–1819. [CrossRef] [PubMed] [Google Scholar]
  18. de Lima AG, Antequera R, de Peres MPS, Snitcosky IML, Federico MHH, Villar RC. Efficacy of low-level laser therapy and aluminum hydroxide in patients with chemotherapy and radiotherapy-induced oral mucositis. Braz Dent J 2010;21:186–192. [CrossRef] [PubMed] [Google Scholar]
  19. Gautam AP, Fernandes DJ, Vidyasagar MS, Maiya GA. Low Level Helium Neon Laser therapy for chemoradiotherapy induced oral mucositis in oral cancer patients – A randomized controlled trial. Oral Oncol sept 2012;48:893–897. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.